Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00086970 | Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors | terminated | Phase 1 | 32 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00028561 | BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors | terminated | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00101244 | SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma | terminated | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00086983 | Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors | terminated | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00089089 | Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas | terminated | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT01416623 | A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies | terminated | Phase 1 | 44 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00424645 | Voraxaze for Delayed Methotrexate Clearance | terminated | Phase 1 / Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00512798 | Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma | terminated | Phase 1 / Phase 2 | 47 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT00062231 | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer | terminated | N/A | 351 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT01286974 | A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors. | terminated | Phase 1 | 3 | AbbottINDUSTRY | 1 | Sep 21, 2012 | clinicaltrials |
| NCT01016327 | Study of NMS-1116354 in Solid Tumors | terminated | Phase 1 | 15 | Nerviano Medical SciencesINDUSTRY | 1 | Sep 7, 2012 | clinicaltrials |
| NCT00511017 | Doxercalciferol in Recurrent Pediatric Solid Tumors | terminated | Phase 1 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT01226901 | A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005) | terminated | Phase 1 | 3 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 28, 2012 | clinicaltrials |
| NCT01147029 | GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy | terminated | Phase 1 | 35 | Cancer Research UKOTHER | 1 | May 1, 2012 | clinicaltrials |
| NCT00804310 | Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors(UCDCC#207) | terminated | Phase 1 | 5 | University of California, DavisOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00253461 | 11C Topotecan PET Imaging | terminated | Early Phase 1 | 7 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00469937 | Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases | terminated | Phase 1 | 9 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01096381 | Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor | terminated | — | 8 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT00296062 | Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | terminated | Phase 1 | 12 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT01299415 | Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor | terminated | Phase 1 | 17 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00112619 | Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors | terminated | Phase 1 | 19 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00176540 | Dextromethorphan in Treating Patients With Fatigue Caused by Cancer | terminated | N/A | 30 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 17, 2011 | clinicaltrials |
| NCT00670605 | Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center | terminated | — | — | Vanderbilt UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00473616 | Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan | terminated | Phase 1 | 60 | AstraZenecaINDUSTRY | 1 | Feb 11, 2011 | clinicaltrials |
| NCT00937664 | Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine | terminated | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
| NCT00733031 | Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918 | terminated | Phase 1 | 75 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT00954148 | Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors | terminated | N/A | 53 | Dallas VA Medical CenterFED | 1 | Jun 30, 2010 | clinicaltrials |
| NCT00003567 | Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | terminated | Phase 1 | 8 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00955292 | Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas | terminated | Phase 1 | 12 | Cylene PharmaceuticalsINDUSTRY | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00497731 | AZD1152 in Patients With Advanced Solid Malignancies-Study 1 | terminated | Phase 1 | 70 | AstraZenecaINDUSTRY | 1 | Jun 22, 2009 | clinicaltrials |
| NCT00497679 | AZD1152 in Patients With Advanced Solid Malignancies-Study 3 | terminated | Phase 1 | 45 | AstraZenecaINDUSTRY | 1 | May 14, 2009 | clinicaltrials |
| NCT00165373 | rhEndostatin Protein Involving Pediatric Patients With Cancer | terminated | Phase 1 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00100347 | Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors | terminated | Phase 1 | 45 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00044785 | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | terminated | Phase 1 | 24 | Wellstat TherapeuticsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jan 24, 2013source: clinicaltrials